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ABSTRACT 
Immunological methods involving pregnancy associ-
ated glycoproteins (PAG) are used for cattle preg-
nancy detection. The faults of these methods could 
be overcomed by using antibodies specific for each 
member of the PAG family. In order to differentiate 
between very similar proteins, preparation of anti-
bodies specific for peptides is a method of choice. In 
this work, we summarize a series of considerations 
regarding peptide design and choose free access 
NCBI, Antigenicity Plot, EMBOSS Antigenic and 
Expasy tools to apply them. We design peptides spe-
cific for different reported PAG members and obtain 
the corresponding polyclonal antibodies for five of 
them. 
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1. INTRODUCTION 
Diagnosis of pregnancy and prompt re-enlistment of 
‘‘non-pregnant’’ cattle into an appropriate reproduction 
protocol are essential components of successful breeding 
programs. Thus, early and accurate pregnancy detection 
is prompted and several systems that use proteins from 
the pregnancy associated glycoprotein (PAG) family 
have been developed [1]. This family can be separated in 
two groups, one of which is expressed only in thopho- 
blastic binucleated cells, being its members detectable as 
a group in maternal blood from the time of implantation. 
The concentration of this group of proteins increases 
steadily in plasma, peaks before parturition, and remains 
detectable for 2-3 months after calving [2]. Immu-
nological reactions involving PAGs have been used to 
design commercial kits for pregnancy detection [3], for 
review see [4]. Variations on detection between methods 
are significant and may be attributed to the quality of the 
anti-PAG antibodies used for each assay [4]. Anti-PAG 
antibodies have been developed using PAG preparations 
purified from placenta, which contain various PAG 
members, or whole PAG proteins as immunogenic mate-
rial. Even when monoclonal antibodies are used, several 
members of the PAG family may be recognized by these 
antibodies, as PAGs may share the recognized epitope. 
Sensitivity and specificity of methods using radioim-
munoassay were improved by the use of heterologous 
anti-PAG antibodies [3] and of monoclonal antibodies 
that recognize only a few members of the PAG family 
[5]. Persistence of some members of the PAG group 
pos-partum also limits the use of the currently existing 
methods. As different members of PAG have distinct 
temporal expression [2], the development of antibodies 
specific for them could help improve the currently ex-
isting techniques. Also, as different PAGs have distinct 
half lives not all the members of the family persist in 
pos-partum serum, thus the use of antibodies that distin-
guish between PAGs could permit accurate pos-partum 
pregnancy detection. The same would apply to the de-
tection of wastage. The objective of this work is to de-
velop antibodies against peptides unique to different 
members of the PAG family, which would presumably 
be specific for one reported PAG.  
Anti-peptide antibodies may be obtained using recom-
binant proteins [6] or synthetic peptides coupled to car-
rier proteins [7] as antigens. The production of antibodies 
using synthetic peptides allows the recognition of spe-
cific regions of proteins and is often found advantageous 
for diagnostic purposes. The selection of the peptide se-
quence is essential for the immunization of the recipient 
organism and for the future detection of the protein or 
domain in its native form. In this work, free access 
NCBI, Antigenicity Plot, EMBOSS Antigenic and Ex-
pasy tools are used for antigenic peptide sequences se-
lection. 
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2. METHODS 
2.1. Peptide Design 
uniqueness: The sequences of the 22 reported bovine 
PAGs were taken from the NCBI database [8] and 
aligned using MultAlin5.4.1. [9]. As in order to consti-
tute an epitope a peptide must be at list 6 aminoacids (aa) 
long (3,000-5,000 Da) [7], unique sequences at least 8 aa 
long were chosen in this work, to assure immunogenicity. 
As only the 13 PAGs expressed exclusively in tho-
phoblastic binucleated cells are candidates to be found in 
serum in posterior use, peptides were selected only for 
them (Figure 1, bold) [2]. The antibodies must recog-
nize only the selected peptide in the context in which 
they will be used, thus chosen sequences need to be ab-
sent not only from other PAGs but also from other serum 
proteins. The BLASTp option of the NCBI database was 
used to search for the possible presence of the peptides 
in other proteins reported on the non redundant (nr) Bos 
taurus proteins database, which considers translated as 
well as determined protein sequences. This led to the 
elimination of 39 of the 90 considered peptides (Figure 
1, underlined).  
antigenicity: The characteristics of the aa contained in 
a peptide determine its antigenicity in the context of the 
protein, where it must be recognized. From the different 
possible criteria, two antigenicity prediction programs 
were used: Antigenicity Plot [10], a tool that computes 
and plots the antigenicity along a polypeptide chain, as 
predicted by an algorithm; and EMBOSS Antigenic [11], 
which predicts potentially antigenic regions of a protein 
sequence considering experimental data. Nine peptides 
resulted non antigenic by any of the tools, and were not 
furthered analyzed. 
exposure: In order to be detected in the native protein, 
a peptide must be exposed in its surface. Four highly 
variable domains which are exposed in surface loops 
have been reported for PAGs [12]. Twentyseven of the 
considered peptides are present in these domains, and 
were selected for further analysis.  
posttranslational modification: If the peptide used for 
antibody preparation is modified in the native protein the 
antibodies developed against it might be unable to detect 
it in its context. Possible posttranslational modifications 
 
 
Figure 1. Alignment of the 13 bovine PAGs of probable early expression during pregnancy. Candidate peptides se-
lected based on length and uniqueness on the PAG family are showed in bold. Peptides eliminated because of their 
homology to other bovine proteins are underlined. The five peptides used for antibody obtainment are highlighted and 
named underneath. 
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and signal peptides in the protein were analyzed using 
the whole protein sequences with the Expasy tools [13]: 
NetNGlyc (N-glycosylation), YingOYang (O-beta- 
GlcNAc attachment), NetGlycate (glycation of epsilon 
amino groups of lysines), NetCGlyc (C-mannosylation), 
NetPhos (phosphorylation), SignalP from NetNglyc 
(signal peptides). Posttranslational modifications were 
predicted for eleven candidate peptides and none of the 
peptides under study so far were predicted to be part of a 
signal sequence.  
synthesis: Difficulties in peptide synthesis compro-
mise the purity of the product, with an augment of con-
taminating peptides. Peptide Calculator [14] was used to 
estimate peptide synthesis capability and solubility, 1 
peptide was discarded.  
2.2. Antibody Production 
From the 15 peptides chosen, 5 (Figure 1) were syn-
thezised by GenBiotech, Argentina. The peptides were 
coupled to rabbit serum albumin using 3-Maleimido- 
benzoic acid N-hydroxysuccinimide ester (MBS) [7]. 
MBS (25 mg/ml) was first linked to the peptides (5 
mg/ml) and afterwards to the carrier (10 mg/ml) in order 
to favor linkage by the amino-terminal group of the pep-
tide. Coupling efficiency was tested by filtrating the re-
action mix through Millipore Centricon® Centrifugal 
Filter Units (cut-off 10 kDa) (Millipore, Bedford, MA, 
USA) followed by peptide concentration determination 
of the filtrate using a QuBit devise (GE Healthware). 
The efficiency was stated as coupled peptide (used mi-
nus filtered)/total peptide (used)) and was between 80 
and 85% in every case. 
Four New Zealand rabbits (one rabbit per peptide) 
were immunized by four subcutaneous injections of 250 
g peptide with equal amounts of adjuvant. Samples 　
were taken 30, 60 and 90 days after the first boost. 
2.3. Antibodies Quality Analysis 
The presence and peptide specificity of antibodies was 
analyzed by dot blot, immobilizing the peptides (10 g) 
and fetuin (10 g), used as specificity control for pro-
teins in general, on PVDF membranes (Hybond-P, GE 
Heathware).  
Placenta from 50-70 days pregnant cows and muscle 
samples were obtained at a local abattoir and transported 
to the laboratory on ice. Protein extracts were prepared 
by homogenizing cubic pieces (2 cm each side) of tissue 
in 5 ml of 20mM Tris-HCl pH 7.6, 2 mM EDTA, 1 mM 
PMSF with Omnimixer Homogenizer (Omni Interna-
tional, Waterbury, CT, USA), followed by centrifugation 
at 27,000 xg for 1 hour. Protein extracts were used for 
native PAGE and blotted to PVDF membranes. 
Antibodies were labeled with biotin using biotinylat-
ing reagent EZ-Link® Sulfo-NHS-SS-Biotin according 
to the supplier’s instructions (Pierce, Thermo Scientific, 
Rockford, IL, USA). PVDF membranes were blocked 
overnight with 1% gelatin in TTBS buffer, which con-
sisted of 20 mM Tris–HCl, pH 7.6, 150 mM NaCl, 0.1% 
v/v Tween 20, followed by two 5 min washes with TTBS. 
After incubation with the indicated dilution of 
anti-peptide antibody for 1 h, membranes were washed 
twice with TTBS for 10 min and treated with 1:8000 di-
lution in TTBS of 1 mg/ml of peroxidase-conjugated 
streptavidin during 1 h at room temperature. After three 
washes with TTBS and one with TBS (TTBS without 
Tween 20), peroxidase activity was revealed using en-
hanced chemiluminescence detection with SuperSignalR 
WestPico Chemiluminiscent Substrate, Thermo Scientific, 
USA, according to manufacturer’s instructions. Controls 
without anti-peptide antibodies and using pre-immuniza- 
tion sera were done. These showed no signal for dot blots 
and for western blots (data not shown). 
3. RESULTS AND DISCUSSION  
In order to obtain antibodies specific for different PAGs 
we aimed to establish a method to select exclusive and 
highly antigenic peptides for each of them, and develop 
the corresponding antibodies using chemically synthe-
sized peptides. Most often, peptide exclusiveness is the 
only item considered for peptide design. We listed a se-
ries of considerations to be made in peptide sequence 
selection in order to augment the possibility for them to 
impress the immunological system of the animal in 
which the antibodies will be developed and to produce 
antibodies capable of recognizing the peptide in the na-
tive protein upon further use. Our simple guidelines use 
NCBI, Antigenicity Plot, EMBOSS Antigenic and Ex-
pasy tools, chosen from the free access available ones. 
To test the designed peptides we selected five of them, 
corresponding to different PAGs, had them synthesized, 
coupled them to a carrier protein and used them for an-
tibody development in rabbits by our custom protocol, 
which is based on [7]. The presence of antibodies was 
analyzed by dot-blot, obtaining positive reaction in every 
case (Figure 2A); the corresponding controls: fetuin, 
assays without primary antibody and pre-immune serum, 
gave no signal. Dot-blot assays were done to analyze the 
possibility of crossed peptide detection showing each 
serum recognized exclusively the peptide used to pro-
duce it, indicating specificity (Figure 2B). 
To analyze recognition of the peptides in their context, 
western blots of placenta native protein extracts (50-70 
days post-insemination) were done, the results obtained 
using anti-PAG18 are shown (Figure 3). For anti-PAG18, 
two protein bands are detected in placenta that are not 
seen when analysis is performed with pre-immune serum  
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Figure 2. Specificity of anti-peptide antibodies. (A) Dot-blots 
of the named peptides and fetuin (10 g each), as a negative 　
control, in PVDF membranes with the corresponding antibod-
ies. Dilutions are noted at the bottom. (B) A representative 




Figure 3. Recognition of peptides in the 
native protein. A representative result for 
anti-18.2 is shown. 1- Muscle and 2- Pla-
centa protein extracts were used for 
non-denaturing electrophoresis followed 
by western blot with anti-18.2 peptide 
(1:500). 
 
or without antibody (data not shown) or in other tissue 
(muscle, Figure 3, line 1). The presence of two bands 
may indicate different glycosilation or charge states of 
PAG 18, or the presence of an additional, still not re-
ported member of the PAG family that also contains the 
used peptide. As more than 100 genes may encode PAGs 
in ruminant placenta [15] the last possibility can not be 
ruled out. 
The considerations made for peptide design in this 
work allowed the development of specific antibodies in 
all five randomly chosen cases. The preparation of anti-
bodies specific for different PAGs through the use of 
chemical peptides, designed not only based on unique-
ness in PAGs but also following the other guidelines 
listed here, may help obtain better results in ruminant 
pregnancy detection. These simple guidelines may serve 
prepare specific antibodies for other purposes as well. 
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